Sarbanes Votes to Cap Insulin Costs for American Families

Congressman John Sarbanes (D-Md.) today voted to pass legislation which would cap out-of-pocket costs for insulin – a lifesaving drug that millions of American rely on every day – at $35 per month for Americans covered by private health insurance plans or Medicare Part D.

This legislation, the Affordable Insulin Now Act (H.R. 6833), would take long-overdue action to curb skyrocketing insulin costs and ensure that millions of Americans living with diabetes have affordable access to this medication that is critical to maintaining their health.

“Insulin costs over ten times more in the United States than in other high-income countries, and many Americans are forced to make impossible decisions that put their health at risk because they cannot afford it,” said Congressman Sarbanes. “I voted for this legislation today to ensure that the millions of Americans with diabetes have access to this lifesaving drug regardless of drug companies’ decisions to charge skyrocketing prices. I urge the Senate to work quickly to send this legislation to President Biden’s desk.”

He continued, “Lowering prescription drug prices for families has remained one of my highest priorities in Congress. I will continue to call for reforms that rein in out-of-control health care and prescription drug costs for American families.”